ArticleEuropean heart journal. Acute cardiovascular care2025
Catheter ablation for refractory ventricular tachycardia early after acute myocardial infarction: management, electrophysiological characteristics, and outcomes.
Article in European heart journal. Acute cardiovascular care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
aimsRefractory ventricular tachycardia (VT) is a rare but lethal condition in the early phase of acute myocardial infarction (AMI). Its intracardiac mechanism and role of catheter ablation is under-determined. The current study aims to evaluate the feasibility and safety of catheter ablation for refractory ventricular tachycardia in early AMI. METHODS AND
resultsBetween 2022 and 2024, 12 835 consecutive patients with AMI were screened, and VT/ventricular fibrillation (VF) was developed in 261 (2.0%) patients; among them 51 (19.5%) were identified as refractory VT storm necessitating intensive intervention, and finally 19 patients received bailout ablation for incessant VT. Their clinical and electrophysiological characteristics and outcomes were collected and analysed. For these, 19 patients underwent rescue ablation, VT was developed at a median of 4 days after the onset of AMI and became incessant 2 days after the first VT occurrence, despite revascularization, anti-arrhythmic agents, sedation, and haemodynamic support. Through intracardiac mapping, VTs were all identified as scar-related reentry within the territory of the culprit artery. The endocardial mappable cycle length (CL) was 65.3 ± 7.6% to the total CL. Energy delivery at either component of critical isthmus from the endocardium successfully eliminated VT, and no foci trigger was observed after VT termination. Subsequent substrate modification was performed around the termination site. After the index procedure, recurrent sustained VT was documented in two, and one patient received repeated ablation. After a total of 20 procedures, VTs were all well subsided after the index procedure in all except for one patient who died of cerebral haemorrhage. The remaining patients were discharged alive. After a median of 18-month follow-up, one patient developed recurrent VF, and no sudden cardiac death occurred.
conclusionScar-related reentry is responsible for refractory VT early after AMI, and ablation at critical isthmus is effective in VT suppression. Its indication and optimal timing of catheter ablation should be evaluated in prospective analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.